Familial PD caused by a mutation in glucocerebrosidase (GBA1) leads to the metabolic dysregulation of the important bioactive lipid ceramide and imbalance of its intermediate glucosylceramide (Plotegher et al., 2019). The gene discussed is GBA1; the disease is Parkinson disease.